45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
14,184
Insurances with rates
3
CPT / HCPCS codes
11,290
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 41096 | PACLITAXEL-PROTEIN BOUND 100 MG IV SOLR | $123,245 | $86,272 | — | — | 0 |
| 48729 | NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML IVES SUSP | $87,000 | $60,900 | — | — | 0 |
| 25339 | EMICIZUMAB-KXWH 150 MG/ML SUBQ SOLN | $85,093 | $59,565 | — | — | 0 |
| 48105 | GLOFITAMAB-GXBM 1 MG/ML IV SOLN (>10 MG DOSE 10 ML MIXTURE COMPONENT) | $84,614 | $59,230 | — | — | 0 |
| 49698 | DATOPOTAMAB DERUXTECAN-DLNK 100 MG IV SOLR | $72,897 | $51,028 | — | — | 0 |
| 47433 | NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20 ML IV SOLN | $56,694 | $39,686 | — | — | 0 |
| 49119 | IMETELSTAT 188 MG IV SOLR | $54,674 | $38,272 | — | — | 0 |
| 49107 | LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR | $49,327 | $34,529 | — | — | 0 |
| 34032 | YTTRIUM-90 (Y-90 THERASPHERE) GLASS MICROSPHERES | $44,379 | $31,065 | — | — | 0 |
| 48723 | TARLATAMAB-DLLE 10 MG IV SOLR | $41,400 | $28,980 | — | — | 0 |
| 49118 | TARLATAMAB-DLLE 10 MG IV SOLR | $41,381 | $28,967 | — | — | 0 |
| 31590 | LURBINECTEDIN 4 MG IV SOLR | $36,615 | $25,631 | — | — | 0 |
| 48264 | ELRANATAMAB-BCMM 40 MG/ML SUBQ SOLN | $36,020 | $25,214 | — | — | 0 |
| 31766 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) IV SOLN | $35,526 | $24,868 | — | — | 0 |
| 44221 | PERTUZUMAB-TRASTUZUMAB-HY-ZZXF 1,200 MG-600MG- 30000 UNIT/15ML SUBQ SOLN | $35,072 | $24,550 | — | — | 0 |
| 35787 | AMIVANTAMAB-VMJW 50 MG/ML IV SOLN | $32,941 | $23,059 | — | — | 0 |
| 46784 | DOSTARLIMAB-GXLY 50 MG/ML IV SOLN | $30,675 | $21,473 | — | — | 0 |
| 33152 | TESTOSTERONE 75 MG IMPL PLLT | $29,210 | $20,447 | — | — | 0 |
| 22762 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) IV SOLN | $29,102 | $20,371 | — | — | 0 |
| 46427 | TREMELIMUMAB-ACTL 20 MG/ML IV SOLN | $26,910 | $18,837 | — | — | 0 |
| 39886 | SACITUZUMAB GOVITECAN-HZIY 180 MG IV SOLR | $25,873 | $18,111 | — | — | 0 |
| 49225 | TORIPALIMAB-TPZI 240 MG/6 ML (40 MG/ML) IV SOLN | $25,650 | $17,955 | — | — | 0 |
| 38133 | CEMIPLIMAB-RWLC 50 MG/ML IV SOLN | $25,491 | $17,844 | — | — | 0 |
| 8925 | TECLISTAMAB-CQYV 90 MG/ML SUBQ SOLN | $24,915 | $17,441 | — | — | 0 |
| 36564 | LUSPATERCEPT-AAMT 75 MG SUBQ SOLR | $24,220 | $16,954 | — | — | 0 |
| 41099 | PEMBROLIZUMAB 100 MG/4 ML (25 MG/ML) IV SOLN | $24,182 | $16,927 | — | — | 0 |
| 49775 | TISLELIZUMAB-JSGR 10 MG/ML IV SOLN | $23,077 | $16,154 | — | — | 0 |
| 36561 | FAM-TRASTUZUMAB DERUXTECAN-NXKI 100 MG IV SOLR | $21,546 | $15,082 | — | — | 0 |
| 45000385 | HC OPEN TX TRIMALLEOLAR ANKLE FX INCL INT FIXATION MEDIAL/ LATERAL MALLEOLUS W/O FIXATION POST LIP | $20,934 | $14,654 | — | — | 0 |
| 31562 | DARATUMUMAB-HYALURONIDASE-FIHJ 1,800 MG-30,000 UNIT/15 ML SUBQ SOLN | $20,904 | $14,633 | — | — | 0 |
| 25073 | DURVALUMAB 50 MG/ML IV SOLN | $19,204 | $13,443 | — | — | 0 |
| 43293 | PANITUMUMAB 400 MG/20 ML (20 MG/ML) IV SOLN | $19,049 | $13,334 | — | — | 0 |
| 38791 | TRASTUZUMAB-QYYP 420 MG IV SOLR | $18,720 | $13,104 | — | — | 0 |
| 11021 | RABIES IMMUNE GLOBULIN (PF) 300 UNIT/ML IM SOLN | $17,892 | $12,524 | — | — | 0 |
| 44455 | TRABECTEDIN 1 MG IV SOLR | $17,885 | $12,520 | — | — | 0 |
| 35727 | PEGFILGRASTIM (NEULASTA) 6 MG/0.6ML SUBQ SYRG | $17,714 | $12,400 | — | — | 0 |
| 33962 | ROMIPLOSTIM 500 MCG SUBQ SOLR | $17,559 | $12,291 | — | — | 0 |
| 11439 | TRASTUZUMAB 150 MG IV SOLR | $17,205 | $12,044 | — | — | 0 |
| 32073 | IRINOTECAN LIPOSOMAL 4.3 MG/ML IV DISP | $16,978 | $11,885 | — | — | 0 |
| 8690 | LANREOTIDE 60 MG/0.2 ML SUBQ SYRG | $16,803 | $11,762 | — | — | 0 |
| 75000072 | HC UNLISTED PROCEDURE SMALL INTESTINE | $16,774 | $11,742 | — | — | 0 |
| 36100853 | HC SPLIT-THICKNESS AUTOGRAFT TRUNK/ARMS/LEGS FIRST 100 SQ CM OR LESS OR 1% OF BODY AREA OF INFANTS/C | $16,166 | $11,316 | — | — | 0 |
| 46561 | PEMIVIBART 125 MG/ML IV SOLN | $15,939 | $11,157 | — | — | 0 |
| 75000125 | HC ESOPH FLEX TRANSORAL W/ABLATION TUMOR/POLYP/OTHER LESIONS | $15,103 | $10,572 | — | — | 0 |
| 36000038 | HC OR ACUITY 4 | $14,991 | $10,494 | — | — | 0 |
| 34738 | AVELUMAB 20 MG/ML IV SOLN | $14,907 | $10,435 | — | — | 0 |
| 42347 | RAMUCIRUMAB 10 MG/ML IV SOLN | $14,790 | $10,353 | — | — | 0 |
| 35333 | BENRALIZUMAB 30 MG/ML SUBQ ATIN | $14,769 | $10,338 | — | — | 0 |
| 41102 | NIVOLUMAB 240 MG/24 ML IV SOLN | $14,474 | $10,132 | — | — | 0 |
| 8692 | LUPRON 3.75MG IM KIT | $14,204 | $9,943 | — | — | 0 |
Showing top 50 of 14,184 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.